BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36163034)

  • 41. General practice perspectives on a bowel cancer screening quality improvement intervention using the Consolidated Framework for Implementation Research.
    Holden CA; Turnbull D; Frank OR; Olver I
    Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
    Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
    Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of family history of colorectal cancer in primary care: perceptions of first degree relatives of people with colorectal cancer.
    Cameron E; Rose S; Carey M
    Patient Educ Couns; 2014 Mar; 94(3):427-31. PubMed ID: 24380670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial.
    Green BB; Anderson ML; Cook AJ; Chubak J; Fuller S; Meenan RT; Vernon SW
    J Gen Intern Med; 2022 Apr; 37(5):1073-1080. PubMed ID: 34047921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
    Doroudi M; Schoen RE; Pinsky PF
    Cancer; 2017 Dec; 123(24):4815-4822. PubMed ID: 28976536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality improvement intervention to increase colorectal cancer screening at the primary care setting: a cluster-randomised controlled trial.
    Irazola V; Santero M; Sanchez M; Tristao I; Ruiz JI; Spira C; Ismael J; Cavallo AS; Gutierrez L; Mazzaresi Y; Nadal AM; García Elorrio E;
    BMJ Open Qual; 2023 Jun; 12(2):. PubMed ID: 37339820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.
    Roux A; Cholerton R; Sicsic J; Moumjid N; French DP; Giorgi Rossi P; Balleyguier C; Guindy M; Gilbert FJ; Burrion JB; Castells X; Ritchie D; Keatley D; Baron C; Delaloge S; de Montgolfier S
    BMC Cancer; 2022 May; 22(1):507. PubMed ID: 35524202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer.
    Obón-Santacana M; Díez-Villanueva A; Alonso MH; Ibáñez-Sanz G; Guinó E; López A; Rodríguez-Alonso L; Mata A; García-Rodríguez A; Palomo AG; Molina AJ; Garcia M; Binefa G; Martín V; Moreno V
    BMC Med; 2021 Nov; 19(1):261. PubMed ID: 34743725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.
    Schroy PC; Emmons KM; Peters E; Glick JT; Robinson PA; Lydotes MA; Mylvaganam SR; Coe AM; Chen CA; Chaisson CE; Pignone MP; Prout MN; Davidson PK; Heeren TC
    Am J Prev Med; 2012 Dec; 43(6):573-83. PubMed ID: 23159252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
    van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
    Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Responding to Young People's Health Risks in Primary Care: A Cluster Randomised Trial of Training Clinicians in Screening and Motivational Interviewing.
    Sanci L; Chondros P; Sawyer S; Pirkis J; Ozer E; Hegarty K; Yang F; Grabsch B; Shiell A; Cahill H; Ambresin AE; Patterson E; Patton G
    PLoS One; 2015; 10(9):e0137581. PubMed ID: 26422235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tailored message interventions versus typical messages for increasing participation in colorectal cancer screening among a non-adherent population: A randomized controlled trial.
    Hirai K; Ishikawa Y; Fukuyoshi J; Yonekura A; Harada K; Shibuya D; Yamamoto S; Mizota Y; Hamashima C; Saito H
    BMC Public Health; 2016 May; 16():431. PubMed ID: 27220976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
    Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
    Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can a print-based intervention increase screening for first degree relatives of people with colorectal cancer? A randomised controlled trial.
    Carey M; Sanson-Fisher R; Macrae F; Cameron E; Hill D; D'Este C; Simmons J; Doran C
    Aust N Z J Public Health; 2016 Dec; 40(6):582-587. PubMed ID: 27625308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.
    Green BB; Coronado GD; Schwartz M; Coury J; Baldwin LM
    Implement Sci; 2019 May; 14(1):53. PubMed ID: 31142348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Decision Aid to Promote Appropriate Colorectal Cancer Screening among Older Adults: A Randomized Controlled Trial.
    Lewis CL; Kistler CE; Dalton AF; Morris C; Ferrari R; Barclay C; Brewer NT; Dolor R; Harris R; Vu M; Golin CE
    Med Decis Making; 2018 Jul; 38(5):614-624. PubMed ID: 29847251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementing a mHealth intervention to increase colorectal cancer screening among high-risk cancer survivors treated with radiotherapy in the Childhood Cancer Survivor Study (CCSS).
    Henderson TO; Bardwell JK; Moskowitz CS; McDonald A; Vukadinovich C; Lam H; Curry M; Oeffinger KC; Ford JS; Elkin EB; Nathan PC; Armstrong GT; Kim K
    BMC Health Serv Res; 2022 May; 22(1):691. PubMed ID: 35606736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.